125 related articles for article (PubMed ID: 32870256)
1. MicroRNA-183 as a Novel Regulator Protects Against Cardiomyocytes Hypertrophy via Targeting TIAM1.
Gong FH; Chen XL; Zhang Q; Xiao XQ; Yang YS; Song BJ; Chao SP; Cheng WL
Am J Hypertens; 2022 Jan; 35(1):87-95. PubMed ID: 32870256
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-122 promotes cardiomyocyte hypertrophy via targeting FoxO3.
Song G; Zhu L; Ruan Z; Wang R; Shen Y
Biochem Biophys Res Commun; 2019 Nov; 519(4):682-688. PubMed ID: 31543343
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
4. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy.
Xu XD; Song XW; Li Q; Wang GK; Jing Q; Qin YW
J Cell Physiol; 2012 Apr; 227(4):1391-8. PubMed ID: 21618527
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
Ding YQ; Zhang YH; Lu J; Li B; Yu WJ; Yue ZB; Hu YH; Wang PX; Li JY; Cai SD; Ye JT; Liu PQ
Acta Pharmacol Sin; 2021 Sep; 42(9):1422-1436. PubMed ID: 33247214
[TBL] [Abstract][Full Text] [Related]
7. A novel circ_0018553 protects against angiotensin-induced cardiac hypertrophy in cardiomyocytes by modulating the miR-4731/SIRT2 signaling pathway.
Zuo H; Li L; Wang X; Chen S; Liao Z; Wei S; Ruan H; Li T; Chen J
Hypertens Res; 2023 Feb; 46(2):421-436. PubMed ID: 36474029
[TBL] [Abstract][Full Text] [Related]
8. MiR-30e-5p is sponged by Kcnq1ot1 and represses Angiotensin II-induced hypertrophic phenotypes in cardiomyocytes by targeting ADAM9.
Wang W; Wu C; Ren L; Bao Y; Han Y; Li C; Li Y
Exp Cell Res; 2020 Sep; 394(2):112140. PubMed ID: 32535037
[TBL] [Abstract][Full Text] [Related]
9. MiR-423-5p Inhibition Exerts Protective Effects on Angiotensin II-Induced Cardiomyocyte Hypertrophy.
Xu M; Liu D; Gao X; Wang Z; Zhang L; Fan H
Tohoku J Exp Med; 2023 Feb; 259(3):199-208. PubMed ID: 36517015
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
11. A new miRNA regulator, miR-672, reduces cardiac hypertrophy by inhibiting JUN expression.
Lu Y; Wu F
Gene; 2018 Mar; 648():21-30. PubMed ID: 29339068
[TBL] [Abstract][Full Text] [Related]
12. miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity.
Huang J; Sun W; Huang H; Ye J; Pan W; Zhong Y; Cheng C; You X; Liu B; Xiong L; Liu S
PLoS One; 2014; 9(4):e94382. PubMed ID: 24728149
[TBL] [Abstract][Full Text] [Related]
13. Targeting miR-30d reverses pathological cardiac hypertrophy.
Li J; Sha Z; Zhu X; Xu W; Yuan W; Yang T; Jin B; Yan Y; Chen R; Wang S; Yao J; Xu J; Wang Z; Li G; Das S; Yang L; Xiao J
EBioMedicine; 2022 Jul; 81():104108. PubMed ID: 35752105
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
Liu K; Hao Q; Wei J; Li GH; Wu Y; Zhao YF
J Hypertens; 2018 Sep; 36(9):1847-1857. PubMed ID: 29664809
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
[TBL] [Abstract][Full Text] [Related]
16. MiR-410-3p facilitates Angiotensin II-induced cardiac hypertrophy by targeting Smad7.
Jia G; Liang C; Li W; Dai H
Bioengineered; 2022 Jan; 13(1):119-127. PubMed ID: 34951337
[TBL] [Abstract][Full Text] [Related]
17. MALAT1 regulates hypertrophy of cardiomyocytes by modulating the miR-181a/HMGB2 pathway.
Chen F; Li W; Zhang D; Fu Y; Yuan W; Luo G; Liu F; Luo J
Eur J Histochem; 2022 Jun; 66(3):. PubMed ID: 35726535
[TBL] [Abstract][Full Text] [Related]
18. miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.
Guan X; Wang L; Liu Z; Guo X; Jiang Y; Lu Y; Peng Y; Liu T; Yang B; Shan H; Zhang Y; Xu C
J Mol Cell Cardiol; 2016 Oct; 99():207-217. PubMed ID: 27565029
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.
Wang YS; Zhou J; Hong K; Cheng XS; Li YG
Cell Physiol Biochem; 2015; 35(4):1546-56. PubMed ID: 25792377
[TBL] [Abstract][Full Text] [Related]
20. MiR-378 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting AKT2.
Wang G; Feng L; Liu C; Han Z; Chen X
Int Heart J; 2024; 65(3):528-536. PubMed ID: 38825497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
